BridgeMD
New treatment option for Self-Injurious Behavior
Official title Therapeutic Evaluative Conditioning to Reduce Adolescents' Self-injurious Thoughts and Behaviors During and After Psychiatric Inpatient Hospitalization
ClinicalTrials.gov ID: NCT05796531
What this study is testing
- What it's testing
- Suicide is the 2nd leading cause of death among adolescents, with the highest risk period for suicide being the month following psychiatric inpatient hospitalization. The investigators propose testing a brief, scalable intervention using evaluative conditioning aimed at reducing suicidal thoughts and behaviors among adolescents during and after inpatient hospitalization.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 12 to 19
You may be able to join if
- Be a patient on McLean-Franciscan Child and Adolescent Inpatient Program (MF-CAIP) of Franciscan Children's (FC)
- Be 12-19 years-old
- Own a smartphone
- Have a parent/guardian that can provide permission
- Child can assent
You likely can't join if
- Any factor that impairs an individual's ability to comprehend and effectively participate in the study, including
- an inability to speak or write English fluently
- the presence of gross cognitive impairment due to florid psychosis, intellectual disability, dementia, acute intoxication, etc., or the presence of...
- a potential discharge location anticipated to be a residential program in which the average length of stay is more than 14 days
See the full eligibility criteria
- Be a patient on McLean-Franciscan Child and Adolescent Inpatient Program (MF-CAIP) of Franciscan Children's (FC)
- Be 12-19 years-old
- Own a smartphone
- Have a parent/guardian that can provide permission
- Child can assent
- Presentation to the hospital with non-suicidal self-injury (NSSI), suicidal ideation or a suicide attempt.
- Any factor that impairs an individual's ability to comprehend and effectively participate in the study, including
- an inability to speak or write English fluently
- the presence of gross cognitive impairment due to florid psychosis, intellectual disability, dementia, acute intoxication, etc., or the presence of extremely agitated or violent behavior
- a potential discharge location anticipated to be a residential program in which the average length of stay is more than 14 days
The study team makes the final eligibility decision.
Where it's taking place
- Brighton, Massachusetts, United States
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 12 years to 19 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Brighton, Massachusetts, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.